Authors:
Dippel, EJ
Kereiakes, DJ
Tramuta, DA
Broderick, TM
Shimshak, TM
Roth, EM
Hattemer, CR
Runyon, JP
Whang, DD
Schneider, JF
Abbottsmith, CW
Citation: Ej. Dippel et al., Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management, CATHET C IN, 52(3), 2001, pp. 279-286
Authors:
Kereiakes, DJ
Kleiman, NS
Fry, E
Mwawasi, G
Lengerich, R
Maresh, K
Burkert, ML
Aquilina, JW
DeLoof, M
Broderick, TM
Shimshak, TM
Citation: Dj. Kereiakes et al., Dalteparin in combination with abciximab during percutaneous coronary intervention, AM HEART J, 141(3), 2001, pp. 348-352
Authors:
Kereiakes, DJ
Broderick, TM
Abbottsmith, C
Shimshak, TM
Citation: Dj. Kereiakes et al., Bleeding risks and vascular complications following abciximab therapy for percutaneous coronary intervention: A new look at an old problem, J INVAS CAR, 12(2), 2000, pp. 95-98
Citation: Dj. Kereiakes et al., Therapeutic adjuncts for immediate transfer to the catheterization laboratory in patients with acute coronary syndromes, AM J CARD, 86(12B), 2000, pp. 10M-17M